Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$57.32 USD

57.32
16,757,588

-0.08 (-0.14%)

Updated May 21, 2024 04:00 PM ET

After-Market: $57.30 -0.02 (-0.03%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (233 out of 248)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Headquartered in Woonsocket, RI, CVS Health Corporation (formerly known as CVS Caremark Corporation) is a pharmacy innovation company with integrated offerings across the entire spectrum of pharmacy care. On Sep 3, 2014, CVS Caremark Corporation announced a change of its corporate name to CVS Health to reflect its broader health care commitment. In Nov 2018, CVS Health completed the $70-billion consolidation of insurance-giant Aetna. With the acquisition, the segments of CVS Health have been realigned.

Sanghamitra Saha headshot

Want to Tap Merger Mania? Play Top-Ranked Health Care ETFs

by Sanghamitra Saha

What is driving Healthcare merger-mania and how to tap it with ETFs.

    Rite Aid-Albertsons Deal: US SEC Sanctions Proxy Materials

    by Zacks Equity Research

    Rite Aid (RAD) is moving closer to completing its previously announced merger with Albertsons. The company's shareholders are going to cast their votes regarding the deal on Aug 9.

      Benjamin Rains headshot

      Should You Buy Grocery Stocks, WMT, COST, TGT, After Kroger's Strong Quarter?

      by Benjamin Rains

      Shares of Kroger (KR) surged over 10% on Thursday to inch near their 52-week high after the company posted better-than-expected quarterly results. Investors were also likely pleased to see that the grocery chain's e-commerce initiatives started to pay off. The question is should investors think about buying grocery stocks as Amazon-based (AMZN) fears seem to have been overblown.

        Urmimala Biswas headshot

        Walgreens-GE Faceoff: How Impactful is it for Dow Investors?

        by Urmimala Biswas

        The stock performance of Walgreens Boots (WBA) currently does not offer much conviction. Over the past year, shares show a decline of 17.9%.

          Humana, Walgreens Team Up to Provide Better Senior Care

          by Zacks Equity Research

          Humana (HUM) ties up with Walgreens to provide better primary care and other services to seniors of the Kansas City Community.

            Anthem Boosts Integrated Care With Aspire Health Buyout

            by Zacks Equity Research

            Anthem's (ANTM) acquisition of Aspire Health points to its increased efforts in comprehensive community-based palliative care space.

              Benjamin Rains headshot

              One Year After Amazon Bought Whole Foods, Who's Winning the Grocery War?

              by Benjamin Rains

              Amazon (AMZN) might have forever changed the grocery industry exactly one year ago when the e-commerce giant bought Whole Foods for roughly $14 billion on June 16, 2017. Today, grocery delivery is commonplace across the entire industry.

                Should Value Investors Consider CVS Health (CVS) Stock Now?

                by Zacks Equity Research

                CVS Health (CVS) appears to be a good choice for value investors right now, given its favorable P/E and P/S metrics.

                  Medical Device Industry Outlook - June 2018

                  by Zacks Equity Research

                  The medical device industry's global annual sales is forecast to rise more than 5% a year to reach nearly $800 billion by 2030.

                    Express Scripts' Inside Rx to Cut Medical Costs for the Aged

                    by Zacks Equity Research

                    Express Scripts (ESRX) keeps its commitment towards patient benefit management through subsidiary Inside Rx.

                      Health Insurance Industry Outlook - May 2018

                      by Zacks Equity Research

                      Higher medical enrollment, surging revenues, medical cost management and an increasing share of revenues from complementary services helped results.

                        Fred's Confirms Sale of Specialty Pharmacy Unit, Stock Up

                        by Zacks Equity Research

                        Fred's (FRED) implements its long-standing plans to divest specialty pharmacy segment to CVS Health Corporation.

                          Fred's (FRED) Q4 Loss Widens Year Over Year, Stock Loses 6%

                          by Zacks Equity Research

                          Fred's (FRED) continues to struggle with its front store business. However, the company remains focused on turnaround.

                            CVS Health (CVS) Beats on Q1 Earnings, Revenues Lag Estimate

                            by Zacks Equity Research

                            CVS Health (CVS) witnessed year-over-year growth in Pharmacy Services Segment on the back of growth in pharmacy network and specialty pharmacy volume as well as brand inflation.

                              Fred's Stock Jumps Over 13% in a Day, 2 Things You Must Note

                              by Zacks Equity Research

                              Fred's (FRED) has rescheduled its earnings announcement date.This is solely connected to Fred's plans to divest its specialty pharmacy business.

                                Ryan McQueeney headshot

                                Why Are Walgreens and CVS Shares Surging Today?

                                by Ryan McQueeney

                                Shares of several major pharmaceutical retailers--including Walgreens (WBA) and CVS Health (CVS)--surged in afternoon trading Monday after reports emerged that e-commerce behemoth Amazon (AMZN) has shelved its plan to sell prescription drugs to doctors and hospitals.

                                  Factors Setting the Stage for Fred's (FRED) in Q4 Earnings

                                  by Zacks Equity Research

                                  Fred's (FRED) has been reeling under soft comparable store sales for quite some time now. Let's see if Fred???s strategic initiatives can provide any respite in Q4.

                                    Can Strategic Efforts Aid Fred's to Achieve a Turnaround?

                                    by Zacks Equity Research

                                    Fred's (FRED) focuses on pharmacy organization and expense reduction to achieve turnaround. However, receding comps continue to hurt.

                                      Cigna to Take Over Express Scripts (ESRX) for $67 Billion

                                      by Zacks Equity Research

                                      Per a definitive agreement, Cigna will take over Express Scripts (ESRX) in a cash-and-stock transaction worth $67 billion.

                                        Why Is CVS Health Corporation (CVS) Down -9.2% Since its Last Earnings Report?

                                        by Zacks Equity Research

                                        CVS reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.

                                          Pharmacy Services Aid CVS Health, Aetna Deal an Upside Too

                                          by Zacks Equity Research

                                          CVS Health (CVS) is likely to earn $750 million from near-term synergies after the completion of Aetna acquisition deal.

                                            Walgreens (WBA) May Buy Remaining Stake in AmerisourceBergen

                                            by Zacks Equity Research

                                            Walgreens' (WBA) rumored buyout claim over the remaining stake in AmerisourceBergen comes close on the heels of its rival CVS Health's hefty $69-billion worth acquisition of health insurer, Aetna.

                                              Top Analyst Reports for Broadcom, Canadian National & CVS Health

                                              by Zacks Equity Research

                                              Today's Research Daily features new research reports on 16 major stocks, including Broadcom (AVGO), Canadian National (CNI) and CVS Health (CVS).

                                                CVS Health (CVS) Beats On Q4 Earnings & Revenues Estimates

                                                by Zacks Equity Research

                                                CVS Health (CVS) rides high on strength in Pharmacy Services segment in Q4.

                                                  Health Insurance Stock Outlook - January 2018

                                                  by Zacks Equity Research

                                                  Rapid evolution is being witnessed in the health insurance industry as the players are taking concerted efforts to transform themselves into comprehensive health care providers from their earlier role of traditional payers.